Physician profile
John Moore
NPI 1063824688
$6,182.15
in general payments reported to CMS, 2019-2025
46 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $179 · 2021: $483 · 2022: $632 · 2023: $2,025 · 2024: $1,555 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,737 · Travel and Lodging: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,736.56 |
| Travel and Lodging | $1,574.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,678.33 | 2021-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $895.34 | 2024 | |
| Astellas Pharma US INC | $380.30 | 2019-2024 | Xtandi |
| Janssen Biotech, INC. | $346.21 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $311.88 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $302.61 | 2023-2025 | Gemtesa, Orgovyx |
| Accord Healthcare, INC. | $241.30 | 2022-2023 | |
| Pfizer INC. | $237.33 | 2019-2025 | |
| Boston Scientific Corporation | $232.18 | 2019-2025 | Ams 700 |
| Coloplast Corp | $154.13 | 2019-2025 | Porges Coloplast |
| C. R. Bard, INC. & Subsidiaries | $139.70 | 2021 | |
| Medtronic, INC. | $79.86 | 2023 | Interstim |
| Stryker Corporation | $76.55 | 2023 | Na, Vsp System, Vsp Cranial |
| Neotract INC. | $74.67 | 2020 | |
| Cook Medical LLC | $72.70 | 2024-2025 | Litho 150, S~Curve |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.